• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The challenge of evaluating of SARS-CoV-2 antibody responses among vaccinated transplant patients.

作者信息

Kitano Taito, Campigotto Aaron, Allen Upton

机构信息

Division of Infectious Diseases, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

出版信息

Pediatr Transplant. 2022 Sep;26(6):e14319. doi: 10.1111/petr.14319. Epub 2022 May 26.

DOI:10.1111/petr.14319
PMID:35616121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9348348/
Abstract
摘要

相似文献

1
The challenge of evaluating of SARS-CoV-2 antibody responses among vaccinated transplant patients.评估接种疫苗的移植患者中SARS-CoV-2抗体反应的挑战。
Pediatr Transplant. 2022 Sep;26(6):e14319. doi: 10.1111/petr.14319. Epub 2022 May 26.
2
SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗在移植受者中的抗体反应及突破性感染
J Med Virol. 2023 Apr;95(4):e28736. doi: 10.1002/jmv.28736.
3
Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.实体器官移植受者中灭活 SARS-CoV-2 疫苗和 BNT162b2 mRNA 疫苗的抗体反应差异。
Exp Clin Transplant. 2021 Dec;19(12):1334-1340. doi: 10.6002/ect.2021.0402.
4
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.血清学反应和抗 SARS-CoV-2 疫苗接种的临床保护作用，以及免疫抑制药物在一组肾移植患者中的作用。
Viruses. 2022 Sep 2;14(9):1951. doi: 10.3390/v14091951.
5
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
6
Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update.实体器官移植受者对第四剂SARS-CoV-2疫苗的抗体反应：最新情况
Transplantation. 2022 Jul 1;106(7):e338-e340. doi: 10.1097/TP.0000000000004137. Epub 2022 Apr 15.
7
Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.青少年实体器官移植受者对三种SARS-CoV-2 mRNA疫苗的抗体反应。
Am J Transplant. 2022 Oct;22(10):2481-2483. doi: 10.1111/ajt.17085. Epub 2022 May 13.
8
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.既往 COVID-19 感染和免疫抑制方案会影响肝移植受者对 SARS-CoV-2 疫苗的长期应答。
J Hepatol. 2022 Jul;77(1):152-162. doi: 10.1016/j.jhep.2022.02.015. Epub 2022 Mar 10.
9
The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines.加强针接种间隔时间对 BNT162b2 疫苗接种的实体器官移植受者体液免疫应答的影响。
Viruses. 2024 May 28;16(6):860. doi: 10.3390/v16060860.
10
Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.接种三剂 SARS-CoV-2 mRNA 疫苗的实体器官移植受者与自然感染相比的第四剂后免疫反应。
Viruses. 2022 Oct 19;14(10):2299. doi: 10.3390/v14102299.

本文引用的文献

1
Responsiveness to second and third dose of mRNA COVID-19 vaccination in adolescent and young adult heart transplant recipients.青少年和年轻成年心脏移植受者对第二和第三剂 mRNA COVID-19 疫苗的反应。
Pediatr Transplant. 2022 Sep;26(6):e14272. doi: 10.1111/petr.14272. Epub 2022 Mar 27.
2
Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients.肾移植受者接种第三剂SARS-CoV-2 mRNA疫苗BNT162b2六个月后抗体反应和细胞免疫减弱
Am J Transplant. 2022 May;22(5):1498-1500. doi: 10.1111/ajt.16954. Epub 2022 Jan 28.
3
Towards a population-based threshold of protection for COVID-19 vaccines.针对 COVID-19 疫苗的基于人群的保护阈值。
Vaccine. 2022 Jan 21;40(2):306-315. doi: 10.1016/j.vaccine.2021.12.006. Epub 2021 Dec 15.
4
Persistence of Antibody Responses to the SARS-CoV-2 in Dialysis Patients and Renal Transplant Recipients Recovered from COVID-19.新冠康复的透析患者和肾移植受者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体反应的持久性
Pathogens. 2021 Oct 6;10(10):1289. doi: 10.3390/pathogens10101289.
5
Evidence for antibody as a protective correlate for COVID-19 vaccines.针对 COVID-19 疫苗，抗体作为一种保护相关因素的证据。
Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24.
6
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
7
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.儿童和成人在 COVID-19 临床谱中对 SARS-CoV-2 的抗体反应不同。
Nat Immunol. 2021 Jan;22(1):25-31. doi: 10.1038/s41590-020-00826-9. Epub 2020 Nov 5.
8
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.一种高通量中和抗体检测方法用于 COVID-19 的诊断和疫苗评估。
Nat Commun. 2020 Aug 13;11(1):4059. doi: 10.1038/s41467-020-17892-0.